Covenant Partners’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$913K Hold
7,542
0.27% 41
2025
Q1
$841K Hold
7,542
0.27% 43
2024
Q4
$734K Sell
7,542
-66
-0.9% -$6.42K 0.23% 51
2024
Q3
$875K Buy
7,608
+66
+0.9% +$7.59K 0.25% 57
2024
Q2
$803K Hold
7,542
0.24% 59
2024
Q1
$730K Sell
7,542
-307
-4% -$29.7K 0.21% 66
2023
Q4
$793K Sell
7,849
-90
-1% -$9.09K 0.25% 61
2023
Q3
$809K Sell
7,939
-36
-0.5% -$3.67K 0.29% 53
2023
Q2
$805K Buy
7,975
+126
+2% +$12.7K 0.29% 53
2023
Q1
$722K Sell
7,849
-801
-9% -$73.7K 0.28% 57
2022
Q4
$785K Sell
8,650
-1,809
-17% -$164K 0.32% 49
2022
Q3
$795K Hold
10,459
0.39% 45
2022
Q2
$884K Sell
10,459
-3,102
-23% -$262K 0.41% 44
2022
Q1
$1.19M Buy
13,561
+2,455
+22% +$215K 0.47% 31
2021
Q4
$971K Sell
11,106
-3,709
-25% -$324K 0.36% 56
2021
Q3
$1.21M Buy
14,815
+3,709
+33% +$303K 0.48% 40
2021
Q2
$1.01M Sell
11,106
-3,282
-23% -$299K 0.38% 50
2021
Q1
$1.23M Sell
14,388
-4,669
-25% -$399K 0.49% 33
2020
Q4
$1.8M Buy
19,057
+9,055
+91% +$855K 0.76% 20
2020
Q3
$870K Buy
10,002
+918
+10% +$79.9K 0.42% 51
2020
Q2
$793K Sell
9,084
-1,497
-14% -$131K 0.37% 60
2020
Q1
$872K Buy
10,581
+3,870
+58% +$319K 0.47% 41
2019
Q4
$635K Sell
6,711
-5,256
-44% -$497K 0.3% 80
2019
Q3
$1.04M Buy
11,967
+5,256
+78% +$457K 0.55% 37
2019
Q2
$613K Sell
6,711
-2,120
-24% -$194K 0.33% 78
2019
Q1
$761K Buy
8,831
+2,054
+30% +$177K 0.42% 48
2018
Q4
$521K Buy
+6,777
New +$521K 0.25% 30